https://www.selleckchem.com/sc....reening/fda-approved
sidered as a valid option for complex atherosclerotic lesions involving the aortic bifurcation. The endovascular kissing self-expanding covered stent technique for TASC-II C/D AIOD presented a primary patency equal to ABF at 5 years, with the advantage of less surgical complications and shorter hospitalization. Therefore, it may be considered as a valid option for complex atherosclerotic lesions involving the aortic bifurcation. Aortic aneurysms occur concomitantly with malignancy in approximately 1.0-17.0% of patient
Like
Comment
Share
